Healthcare Edge – ExecEdge

Aktis Oncology Appoints New Chief Medical Officer

Aktis Oncology Appoints New Chief Medical Officer

By Daniella Parra Aktis Oncology said it appointed Akos Czibere, MD, PhD, as Chief Medical Officer. Dr. Czibere has overseen several functional areas in his nearly 20-year career, filed a number of new drug applications and successfully led multiple global...

Agilent Appoints Bret DiMarco as Chief Legal Officer

Agilent Appoints Bret DiMarco as Chief Legal Officer

By Daniella Parra Agilent Technologies, Inc. (NYSE: A) has appointed Bret DiMarco as senior vice president and chief legal officer, also serving as secretary, the company announced Monday. DiMarco, previously the chief legal officer at Pendo.io, has extensive legal and...

Sparrow Pharma Unveils Phase 2 Data on Clofutriben for PMR

Sparrow Pharma Unveils Phase 2 Data on Clofutriben for PMR

By Daniella Parra Sparrow Pharmaceuticals shared data on the combination of clofutriben (SPI-62), an HSD-1 inhibitor, and prednisolone for treating polymyalgia rheumatica (PMR). The company said that HSD-1 inhibition can reduce glucocorticoid side effects while maintaining treatment efficacy and combining...

Nanox Integrates AI for Enhanced Second Opinion CT Scan Reviews

Nanox Integrates AI for Enhanced Second Opinion CT Scan Reviews

By Daniella Parra NANO-X IMAGING LTD (Nasdaq: NNOX) has integrated FDA-cleared AI solutions into its Second Opinions online consultation service, offered by its subsidiary, USARAD Holdings INC, the company said. This platform connects patients with specialists for additional diagnostic consultations,...

Aktis Oncology Appoints Ken Herrmann to Board of Directors

Aktis Oncology Appoints Ken Herrmann to Board of Directors

By Karen Roman Aktis Oncology said it appointed Dr. Ken Herrmann to the Board of Directors. Dr. Herrmann specializes in nuclear medicine and has over a decade of experience in clinical investigation, the company said. “Ken’s joining us on the...

Input your search keywords and press Enter.